NuvoAir
NuvoAir Medical is a Boston-based virtual-first specialty care platform delivering AI-driven cardiopulmonary care for patients with chronic heart and lung conditions. It combines FDA-cleared at-home monitoring devices, mobile apps, and multidisciplinary clinical teams to reduce hospitalizations, and is covered by 100+ health plans.
- Company typePrivate
- Founded2015
- HeadquartersBoston, United States
- Headcount51–100
- GTM typeB2B and B2C
- OfferingSoftware
What NuvoAir does
NuvoAir (operating commercially as NuvoAir Medical) is a Boston-based, venture-backed digital health company that delivers virtual-first specialty care for patients with chronic cardiopulmonary conditions including COPD, asthma, heart failure, hypertension, and sleep disorders. The company's care model combines FDA-cleared at-home monitoring hardware with mobile applications, a provider dashboard, and multidisciplinary clinical teams to provide continuous remote care aimed at predicting exacerbations and reducing hospitalizations. Founded in 2015 with a European research and development base in Stockholm, Sweden, NuvoAir now operates clinics in Prescott and Tucson, Arizona alongside virtual care services covered by more than 100 health plans including Anthem, Centene, Humana, Cigna, UnitedHealthcare, Medicare, and Medicaid.
The core technology stack centers on the Air Next Spirometer — a Bluetooth-connected, FDA 510(k)-cleared and CE-certified Class IIa medical device validated against ATS/ISO standard curves — paired with the NuvoAir Home mobile application (iOS/Android, supporting English, French, German, Italian, Spanish, Swedish, and Dutch), the Air MD professional spirometry app, and the NuvoAir Cough companion app. The platform integrates with Apple HealthKit, Hailie® asthma sensors, and the proprietary NuvoAir Aos inhaler add-on sensor. The provider-facing dashboard unifies outreach, diagnostics, and analytics. Sub-brands include Incredible Heart (cardiology-focused care including weight management and immigration medical examination services) and NuvoAir Cough. Disclosed clinical outcomes include a 31% reduction in all-cause hospitalizations, 52% decrease in total hospital days, 77% drop in all-cause readmissions, and 27% reduction in total medical spend among COPD patients in a published research preprint.
NuvoAir operates a hybrid revenue model spanning (1) subscription-based virtual care services reimbursed by health plans, (2) hardware sales of the Air Next spirometer and consumable disposable turbines, (3) decentralized clinical trial services for pharmaceutical companies and CROs, and (4) clinic-based fee-for-service revenue. Go-to-market combines enterprise field sales targeting health plans, ACOs, and risk-bearing entities (e.g., Privia Medical Group Georgia with 515,000 patient reach and Cary Medical Management for rural North Carolina), partnerships with health systems taking over specialty clinics (Dignity Health Yavapai Regional Medical Group), direct-to-consumer mobile app distribution via the iOS App Store and Google Play, and company-operated physical clinics. The company has raised approximately $28 million across disclosed funding rounds since 2017, including a $12 million Series A led by AlbionVC with Novartis participation in 2021 and a subsequent approximately $10.7 million round in January 2022.
NuvoAir firmographics
Firmographics- Name
- NuvoAir
- Legal name
- NuvoAir US Inc.
- Website
- https://nuvoair.com
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- NuvoAir Medical is a Boston-based virtual-first specialty care platform delivering AI-driven cardiopulmonary care for patients with chronic heart and lung conditions. It combines FDA-cleared at-home monitoring devices, mobile apps, and multidisciplinary clinical teams to reduce hospitalizations, and is covered by 100+ health plans.
- Ownership category
- akta.pro rank
NuvoAir industry classification
Industry- Product category
- Virtual Specialty Care Platform
- NAICS
- Services for the Elderly and Persons with Disabilities (62412)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Home Health Care Services (8082)
- akta.pro primary industry
- Primary Care & General Medicine Virtual Care (HLALAAAA)
- akta.pro secondary industry
- Chronic Condition Virtual Care & Disease Management (Payer-Sponsored) (HLALACAE)
Keywords
Where NuvoAir is headquartered
LocationHeadquarters
- HQ city
- Boston
- HQ country
- United States
- HQ region
- North America
Offices6 records
Markets served
NuvoAir business model
Business model- GTM type
- B2B and B2C
- Offering type
- Software
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Virtual Care Services: Subscription-based care services covered by health plans including Medicare, Medicaid, and commercial insurers. The company provides ongoing virtual care management for patients with chronic cardiopulmonary conditions with continuous monitoring and support.
- Medical Device Sales: Sale of Air Next spirometer devices and consumables (disposable turbines) to patients and healthcare providers for at-home lung function monitoring.
- Clinical Trial Services: Clinical trial services and decentralized clinical trial support for pharmaceutical companies and CROs. NuvoAir provides remote patient monitoring, diagnostics, and data collection for respiratory and cardiopulmonary clinical research.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Multi-year contract | Insurance-covered care services |
| One time/ perpetual license | One time | Immigration Exam - $439 |
| Other | Multi-year contract | Incredible Heart Cardiac Care - Insurance-based |
Go-to-market motion2 records
Distribution channels5 records
Marketing channels4 records
NuvoAir product offering
Product offeringCore offering
NuvoAir delivers virtual-first specialty care for chronic heart and lung conditions, combining FDA-cleared at-home monitoring devices (Air Next Spirometer) with AI-driven software, multidisciplinary care teams, and connected mobile apps for continuous remote patient management. Its services are billed to over 100 health plans (including Medicare, Medicaid, and major commercial insurers), with additional revenue from medical device sales and decentralized clinical trial services for pharmaceutical clients.
Product overview
NuvoAir Medical is a digital health company offering a virtual-first cardiopulmonary care platform that combines FDA-cleared at-home monitoring devices with AI-driven technology and multidisciplinary clinical care teams. The core product ecosystem includes the NuvoAir Home App (patient-facing respiratory monitoring), Air Next Spirometer (FDA 510(k) cleared Bluetooth-connected device), and Air MD (professional spirometry version). The platform delivers services for COPD, asthma, heart failure, hypertension, sleep disorders, and weight management. Supporting offerings include NuvoAir Cough for respiratory monitoring and Incredible Heart for specialized cardiac care. The company operates pulmonary clinics in Tucson and Prescott, Arizona, and partners with health plans (100+ including major insurers), healthcare providers, and pharmaceutical companies across the U.S. and Europe.
Differentiator
Problem solved
Functional benefit
Brands
- Air Next Spirometer: Award-winning professional spirometer designed for home use, CE certified Class IIa Medical Device with FDA 510k clearance. Used with NuvoAir Home app for respiratory monitoring.
- NuvoAir Home
- Air MD
Products and services
- NuvoAir Home App Patient-facing mobile application that connects via Bluetooth to the Air Next spirometer to enable at-home respiratory monitoring, lung function insights, medication and symptom tracking, and automatic data sharing with healthcare providers.
- Air Next Spirometer FDA 510(k) cleared and CE certified Class IIa Bluetooth spirometer measuring FEV1, FVC, and PEF with clinical-grade accuracy, featuring maintenance-free disposable turbines and a 10-year expected lifespan.
- Air MD Professional spirometry app for healthcare providers, supporting up to 8 tests per session with spirometry session grading based on ATS/ERS standards.
- NuvoAir Cough Companion mobile app for cough tracking and respiratory monitoring within NuvoAir's respiratory care ecosystem.
- NuvoAir Home Care Service Virtual-first specialty care service for cardiopulmonary conditions including COPD, asthma, heart failure, and sleep disorders, combining remote monitoring with multidisciplinary care teams for proactive, continuous care.
- Remote Patient Monitoring Service Continuous at-home monitoring service using FDA-cleared devices to track respiratory metrics, enabling early detection of health changes and proactive intervention before exacerbations require hospitalization.
- Incredible Heart Cardiac care service offering virtual and in-person consultations, at-home monitoring devices, and cardiologist services covering heart failure, hypertension, atrial fibrillation, and arrhythmia.
- Incredible Heart Weight Management Program Insurance-approved weight management program supervised by board-certified cardiologists, providing diet and lifestyle guidance, weight loss medications, and smart weight scales delivered to patients' homes.
- Immigration Medical Examination USCIS-designated civil surgeon service providing Form I-693 Immigration Medical Examinations, including two office visits and guidance through the immigration exam process for a flat fee of $439.
- Decentralized Clinical Trial Services Clinical trial services for pharmaceutical companies and CROs providing remote patient monitoring, diagnostics, and data collection for respiratory and cardiopulmonary clinical research.
Quantifiable outcome
- 31% reduction in all-cause hospitalizations
- +4 more outcomes
Companies that use NuvoAir
Customer profileNamed customers4 records
Segments4 records
Ideal customer profiles4 records
NuvoAir technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
Integration5 records
AI capability3 records
Feature4 records
NuvoAir partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core and minor.
- Dignity Health Yavapai Regional Medical GroupcoreNuvoAir Medical opened outpatient pulmonary clinic in Prescott, AZ to continue care established by Dignity Health Yavapai Regional Medical Group. Ensures continued access to high-quality outpatient pulmonary care for Prescott-area residents transitioning from YRMG.
- Dresden PulmonologyminorPartnership to elevate respiratory care in rural Tennessee. NuvoAir's virtual-first care model combined with Dresden Pulmonology's local expertise to improve access to specialty cardiopulmonary care.
- Privia Medical Group - GeorgiacoreCollaboration to enhance access to high-quality cardiopulmonary care for patients throughout Georgia. NuvoAir's multidisciplinary team extends specialty care for COPD, CHF, and Asthma patients, integrating with PMG's network of 380+ providers caring for over 515,000 patients. Represents significant expansion through state's highest performing ACO.
- Cary Medical ManagementcorePartnership to bring high-quality specialty cardiopulmonary care to patients in rural North Carolina. NuvoAir enables primary care clinics under CMM's management to provide in-home and virtual care for patients with complex heart and lung issues including Asthma, COPD, and CHF. This addresses the shortage of respiratory and cardiac specialists in rural areas.
- Various Healthcare ProvidersminorPartnerships with various healthcare providers and pharmaceutical companies across U.S., U.K., and Europe for respiratory disease management and clinical trial services.
Scale indicators10 records
Recent moves8 records
Expansion highlights6 records
NuvoAir competitors and assessment
Company assessmentDirect peers
- Propeller Health: Propeller Health is a digital respiratory health company focused on asthma and COPD management via inhaler sensors and a mobile app, now owned by ResMed. Directly comparable to NuvoAir on target conditions (COPD, asthma), at-home monitoring, and payer-aligned chronic care delivery.
- Wellinks: Wellinks offers virtual-first cardiopulmonary care combining remote monitoring, coaching, and clinical care for COPD and other chronic conditions. Closely comparable business model to NuvoAir with overlapping payer, provider, and chronic-condition VBC strategies.
- Hinge Health: Hinge Health is a virtual specialty care platform delivering condition-specific digital care programs (musculoskeletal) to payers and employers. Comparable to NuvoAir on virtual specialty model, employer/payer GTM, and outcome-anchored value proposition.
- Eko Health: Eko Health builds AI-enabled cardiopulmonary diagnostic tools, including connected stethoscopes and digital auscultation, used in clinical and remote settings. Directly comparable to NuvoAir on connected cardiopulmonary hardware, AI analytics, and clinical integration.
Broad incumbents
- Omada Health: Omada Health is an established virtual chronic disease management platform covering diabetes, hypertension, and behavioral health, serving payers, employers, and health systems. Comparable to NuvoAir in chronic-condition VBC orientation and payer contracting motion, though broader in therapeutic scope.
- Vivify Health: Vivify Health provides a remote patient monitoring platform used by health systems and payers to manage chronic and post-acute patients at home. Comparable to NuvoAir on the RPM infrastructure layer and enterprise health-plan/channel distribution.
- ResMed: ResMed is a global leader in sleep and respiratory care devices and the parent of Propeller Health, with deep payer and provider distribution. Comparable to NuvoAir on respiratory/sleep therapy DME, connected device strategy, and chronic cardiopulmonary patient base.
- Teladoc Health: Teladoc Health operates one of the largest virtual care platforms, including the legacy Livongo chronic condition management business. Overlaps with NuvoAir on virtual specialty care, RPM, and chronic condition management delivered to payers and health systems.
Emerging players
- Biofourmis: Biofourmis combines wearable-based RPM with AI predictive analytics for chronic and post-acute care, including cardiology. Overlaps with NuvoAir on RPM + AI-enabled chronic disease management and health plan / pharma channels.
- Lark Health: Lark Health delivers AI-driven chronic condition coaching and remote monitoring for cardiovascular and metabolic conditions via a mobile platform. Comparable to NuvoAir on AI-enabled virtual chronic disease management and payer-aligned GTM.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
NuvoAir social profiles
Digital presenceNuvoAir compliance and trust
Trust signalCompliance6 records
NuvoAir financial estimates
Financial estimateRevenue estimate
Valuation estimate
NuvoAir leadership team
Management profileNumber of profiles
Profiles6 records
NuvoAir funding detail
Funding detailFunding overview
Funding rounds4 records
Investors7 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
NuvoAir M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about NuvoAir
What does NuvoAir do?
NuvoAir delivers virtual-first specialty care for chronic heart and lung conditions, combining FDA-cleared at-home monitoring devices (Air Next Spirometer) with AI-driven software, multidisciplinary care teams, and connected mobile apps for continuous remote patient management. Its services are billed to over 100 health plans (including Medicare, Medicaid, and major commercial insurers), with additional revenue from medical device sales and decentralized clinical trial services for pharmaceutical clients.
Is NuvoAir a public or private company?
NuvoAir is a private company. It is classified as venture growth investor backed and is currently operating.
When was NuvoAir founded?
NuvoAir was founded in 2015. It employs 51 to 100 people.
Where is NuvoAir based?
NuvoAir is headquartered in Boston, United States, in the North America region.
How does NuvoAir make money?
Three revenue lines are on record. Virtual Care Services are the primary driver. The others are medical Device Sales and clinical Trial Services.
Who are NuvoAir's main competitors?
Direct peers on record are Propeller Health, Wellinks, Hinge Health and Eko Health. Broad incumbents are Omada Health, Vivify Health, ResMed and Teladoc Health. Emerging players are Biofourmis and Lark Health.
Does NuvoAir have an API?
Yes. NuvoAir offers an API exchange system for data exchange with partners. The privacy policy states: "The data exchange might be done via our API exchange system, or via Apple HealthKit's API." Data types exchanged include health data such as spirometry results, medications, and questionnaire responses. Data sharing with partners requires prior explicit consent from users.
What industry is NuvoAir in?
NuvoAir's product category is Virtual Specialty Care Platform. Its primary akta.pro industry code is HLALAAAA, Primary Care & General Medicine Virtual Care, with a secondary code of HLALACAE, Chronic Condition Virtual Care & Disease Management (Payer-Sponsored). Its NAICS code is 62412 and its SIC code is 8011.